Literature DB >> 18495164

Decreased activities of lysosomal acid alpha-D-galactosidase A in the leukocytes of sporadic Parkinson's disease.

Guanghua Wu1, Bo Yan, Xuenan Wang, Xungang Feng, Aimei Zhang, Xintan Xu, Haixin Dong.   

Abstract

Parkinson's disease (PD) is a progressive neurodegenerative disease that affects aged people. Although a number of genes have been linked to familial PD, the genetic causes of sporadic PD that accounts for 90% of all PD cases remain unclear. Accumulating evidence has demonstrated that alpha-synuclein aggregation is essential to the pathogenesis of PD. Recent studies suggest that autophagic-lysosomal system play major roles in the process of alpha-synuclein aggregation. We hypothesized that lysosomal acid hydrolases may be involved in the alpha-synuclein degradation and aggregation. In this study, we examined the activities of 11 lysosomal acid hydrolases in peripheral blood leukocytes of 38 sporadic PD patients and 258 age- and sex-matched healthy controls. The activities of alpha-D-galactosidase A were significantly decreased in sporadic PD patients, compared to age- and sex-matched controls. In contrast, no significant differences of the activities of other 10 lysosomal acid hydrolases was observed. This initial study suggests that decreased activities of lysosomal alpha-D-galactosidase A in the central nervous system may be involved in the degradation and aggregation of alpha-synuclein protein and contribute to the pathogenesis of sporadic PD as a risk factor.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18495164     DOI: 10.1016/j.jns.2008.04.011

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  21 in total

1.  Decreased expression of lysosomal alpha-galactosiase A gene in sporadic Parkinson's disease.

Authors:  Guanghua Wu; Jian Huang; Xungang Feng; Aimei Zhang; Jifeng Li; Shuchao Pang; Kejin Gu; Haixin Dong; Junping Zhang; Huijie Gao; Bo Yan
Journal:  Neurochem Res       Date:  2011-06-05       Impact factor: 3.996

Review 2.  Cerebrospinal fluid biomarkers in Parkinson disease.

Authors:  Lucilla Parnetti; Anna Castrioto; Davide Chiasserini; Emanuele Persichetti; Nicola Tambasco; Omar El-Agnaf; Paolo Calabresi
Journal:  Nat Rev Neurol       Date:  2013-02-19       Impact factor: 42.937

3.  The alpha-galactosidase A p.Arg118Cys variant does not cause a Fabry disease phenotype: data from individual patients and family studies.

Authors:  Susana Ferreira; Alberto Ortiz; Dominique P Germain; Miguel Viana-Baptista; António Caldeira-Gomes; Marta Camprecios; Maria Fenollar-Cortés; Ángel Gallegos-Villalobos; Diego Garcia; José Antonio García-Robles; Jesús Egido; Eduardo Gutiérrez-Rivas; José Antonio Herrero; Sebastián Mas; Raluca Oancea; Paloma Péres; Luis Manuel Salazar-Martín; Jesús Solera-Garcia; Helena Alves; Scott C Garman; João Paulo Oliveira
Journal:  Mol Genet Metab       Date:  2014-11-09       Impact factor: 4.797

Review 4.  Genetic perspective on the role of the autophagy-lysosome pathway in Parkinson disease.

Authors:  Ziv Gan-Or; Patrick A Dion; Guy A Rouleau
Journal:  Autophagy       Date:  2015       Impact factor: 16.016

5.  The Modulatory Effects of the Polymorphisms in GLA 5'-Untranslated Region Upon Gene Expression Are Cell-Type Specific.

Authors:  Susana Ferreira; Carlos Reguenga; João Paulo Oliveira
Journal:  JIMD Rep       Date:  2015-03-13

6.  The lysosomal enzyme alpha-Galactosidase A is deficient in Parkinson's disease brain in association with the pathologic accumulation of alpha-synuclein.

Authors:  Michael P Nelson; Michel Boutin; Tonia E Tse; Hailin Lu; Emily D Haley; Xiaosen Ouyang; Jianhua Zhang; Christiane Auray-Blais; John J Shacka
Journal:  Neurobiol Dis       Date:  2017-12-02       Impact factor: 5.996

Review 7.  Glucocerebrosidase is shaking up the synucleinopathies.

Authors:  Marina Siebert; Ellen Sidransky; Wendy Westbroek
Journal:  Brain       Date:  2014-02-14       Impact factor: 13.501

8.  Alpha galactosidase A activity in Parkinson's disease.

Authors:  R N Alcalay; P Wolf; O A Levy; U J Kang; C Waters; S Fahn; B Ford; S H Kuo; N Vanegas; H Shah; C Liong; S Narayan; M W Pauciulo; W C Nichols; Z Gan-Or; G A Rouleau; W K Chung; P Oliva; J Keutzer; K Marder; X K Zhang
Journal:  Neurobiol Dis       Date:  2018-02-02       Impact factor: 5.996

9.  Impaired Sphingolipid Hydrolase Activities in Dementia with Lewy Bodies and Multiple System Atrophy.

Authors:  T S Usenko; K A Senkevich; A I Bezrukova; G V Baydakova; K S Basharova; A S Zhuravlev; E V Gracheva; A V Kudrevatykh; I V Miliukhina; I V Krasakov; L A Khublarova; I V Fursova; D V Zakharov; A A Timofeeva; Y A Irishina; E I Palchikova; N M Zalutskaya; A K Emelyanov; E Y Zakharova; S N Pchelina
Journal:  Mol Neurobiol       Date:  2022-01-23       Impact factor: 5.590

Review 10.  Neurodegenerative Disease Risk in Carriers of Autosomal Recessive Disease.

Authors:  Sophia R L Vieira; Huw R Morris
Journal:  Front Neurol       Date:  2021-06-04       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.